News
-
-
PRESS RELEASE
Jaguar Health Reports Statistically Significant Improvement in Breast Cancer Patients in its Phase 3 OnTarget Trial for its Cancer Supportive Care Drug Crofelemer
Jaguar Health, Inc. announces positive results for crofelemer in breast cancer patients from OnTarget trial, to be presented at an oncology conference with potential for future submissions. Crofelemer also shows promise in IBS-D patients -
-
-
-
PRESS RELEASE
TUP Capital and Piped Vault Announce Proposed Qualifying Transaction
TUP Capital Inc. and PIPED Vault Inc. announce the signing of a letter of intent for TUP to acquire PIPED, resulting in a reverse takeover. The Transaction will list TUP as a Tier 2 Technology Issuer on the TSX Venture Exchange -
-
-
-
